Himalaya Nutravedics India Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | 1.00x | 1,184,400 | 1,185,600 | ₹13 Cr |
| NII (HNI) | 3.58x | 356,400 | 1,274,400 | ₹4 Cr |
| Retail | 2.50x | 832,800 | 2,085,600 | ₹9 Cr |
| Market Maker | — | 126,000 | — | ₹1 Cr |
| Σ Total | 1.92x | 2,373,600 | 4,545,600 | ₹25 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹127,200 |
| Retail (Max) | 13 | 15,600 | ₹1,653,600 |
| S-HNI (Min) | 14 | 16,800 | ₹1,780,800 |
| B-HNI (Min) | 67 | 80,400 | ₹8,522,400 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 43 | 21 | 14 |
| EBITDA | 8 | 3 | 1 |
| Profit After Tax | 7 | 2 | 0 |
| Net Worth | 16 | 7 | 1 |
| Total Assets | 24 | 11 | 6 |
| Reserves & Surplus | 10 | 3 | 1 |
| Total Borrowing | 5 | 2 | 3 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Funding Working Capital Requirements – 13.75
- Business Development and Digital Marketing Activities – 7.50
- General Corporate Purposes –
Company Overview
Incorporated in June 2022, Himalaya Nutravedics India Limited is a Hyderabad-based Ayurvedic and nutraceutical manufacturing company engaged in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products including Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
The company markets its branded products through healthcare practitioners and also undertakes third-party contract manufacturing. It has expanded its presence across 17 states and one union territory in India. Its manufacturing facility is located in Hyderabad, Telangana, and holds ISO 22000:2018, ISO 9001:2015, and WHO-GMP certifications. As of April 30, 2026, the company had 80 employees.
Competitive Strengths:
- Integrated multi-dosage manufacturing capability
- Doctor acceptance supported by product performance rather than mass advertising
- Long-standing relationships with suppliers and customers
- Geographic expansion over a short operating history
- Broad therapeutic coverage across Ayurvedic and nutraceutical segments